Enhancing the Efficacy of CAR T Cells in the Tumor Microenvironment of Pancreatic Cancer

Pancreatic cancer has the worst prognosis and lowest survival rate among all types of cancers and thus, there exists a strong need for novel therapeutic strategies. Chimeric antigen receptor (CAR)-modified T cells present a new potential option after successful FDA-approval in hematologic malignanci...

Descripción completa

Detalles Bibliográficos
Autores principales: Henze, Janina, Tacke, Frank, Hardt, Olaf, Alves, Frauke, Al Rawashdeh, Wa’el
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353070/
https://www.ncbi.nlm.nih.gov/pubmed/32481570
http://dx.doi.org/10.3390/cancers12061389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353070/
https://www.ncbi.nlm.nih.gov/pubmed/32481570
http://dx.doi.org/10.3390/cancers12061389

Ejemplares similares